Targeting HIV pre-exposure prophylaxis to adolescent sexual minority males in higher prevalence areas of the United States : a modeling study

@inproceedings{Goodreau2018TargetingHP,
  title={Targeting HIV pre-exposure prophylaxis to adolescent sexual minority males in higher prevalence areas of the United States : a modeling study},
  author={Steven Michael Goodreau and Deven T Hamilton and Samuel M Jenness and Patrick Sean Sullivan and Rachel Valencia and Li yan Wang and Richard Louis Dunville and L Cabrerizo Barrios and Eli Samuel Rosenberg},
  year={2018}
}
Purpose—Pre-exposure prophylaxis (PrEP) is an effective and safe intervention to prevent HIV transmission in men who have sex with men; current CDC guidelines indicate its use among highrisk adults. Adolescent sexual minority males (ASMM) also have significant HIV risk, but implementation strategies are likely to differ for this population. We aimed to estimate impact and efficiency of PrEP for ASMM in higher-prevalence US settings, using a variety of implementation strategies and assumptions… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 36 REFERENCES

An HIV Pre-Exposure Prophylaxis Demonstration Project and Safety Study for Adolescent MSM ages 15–17 in the US (ATN 113); AIDS 2016: 21st International AIDS Conference; Durban

S. Hosek, R. Landovitz, B Rudy
  • 2016
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Safety, tolerability and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected women and men: HPTN 077

R Landovitz, S Li, B Grinsztejn
  • International AIDS Society Paris
  • 2017
VIEW 1 EXCERPT

Pre-Exposure Prophylaxis: A Narrative Review of Provider Behavior and Interventions to Increase PrEP Implementation in Primary Care

Andrew Silapaswan, Douglas Krakower, Kenneth H. Mayer
  • Journal of General Internal Medicine
  • 2016
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…